Pralsetinib

Definition: Pralsetinib, sold under the brand name Gavreto, is a medication approved for RET mutation-positive medullary thyroid cancer (MTC) and RET fusion-positive differentiated thyroid cancer (DTC) refractory to radioactive iodine (RAI) therapy. Pralsetinib is a tyrosine kinase inhibitor. It is taken by mouth. source: Wikipedia

ID

926318003

Name

Pralsetinib

Previous ID

40712211000001100

ID date

6 Feb 2023